Summary
Heng Pan is a computational biologist and Principal Investigator at Peking University with nine years of experience dissecting DNA methylation machinery and its roles in embryonic development and cancer. Trained with a PhD in Biomathematics, Bioinformatics, and Computational Biology from Weill Cornell, he blends deep computational skills with hands-on experimental collaboration to develop mutation-calling algorithms and epigenomic classifiers for hematologic malignancies. His prior work at Weill Cornell spanned tumor epigenomic evolution, TET protein mechanisms in hESCs, and pipelines for single-cell and bulk RNA-seq analyses, demonstrating both methodological innovation and translational focus. Heng has experience translating computational discoveries into clinically relevant stratification and resistance signatures, notably in DLBCL, CLL, and ALCL. Based in Beijing, he leads a research program that marries algorithm development with mechanistic studies—often revealing regulatory nuances of methylation not apparent from bulk assays alone.
9 years of coding experience
4 years of employment as a software developer
Doctor of Philosophy (PhD), Biomathematics, Bioinformatics, and Computational Biology, Doctor of Philosophy (PhD), Biomathematics, Bioinformatics, and Computational Biology at Joan & Sanford I. Weill Medical College of Cornell University
Bachelor of Science (BS), Biology, General & Applied Mathematics, Bachelor of Science (BS), Biology, General & Applied Mathematics at Peking University
Chinese, English